Zachary Roberts - Jan 3, 2023 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
EVP of R&D
Signature
/s/Veer Bhavnagri, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
3
Date filed
1/9/2023, 04:19 PM
Previous filing
Mar 7, 2022
Next filing
Jan 24, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.